CA2202467A1 - Use of anthocyanidin and derivatives for treatment of retroviral infections - Google Patents

Use of anthocyanidin and derivatives for treatment of retroviral infections

Info

Publication number
CA2202467A1
CA2202467A1 CA 2202467 CA2202467A CA2202467A1 CA 2202467 A1 CA2202467 A1 CA 2202467A1 CA 2202467 CA2202467 CA 2202467 CA 2202467 A CA2202467 A CA 2202467A CA 2202467 A1 CA2202467 A1 CA 2202467A1
Authority
CA
Canada
Prior art keywords
glycosyl
group
groups
anthocyanidin
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2202467
Other languages
English (en)
French (fr)
Inventor
Oyvind M. Andersen
Dag E. Helland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIFOB Universitetsforskning Bergen (Bergen Univ Res Foundation)
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2202467A1 publication Critical patent/CA2202467A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2202467 1994-10-13 1995-10-10 Use of anthocyanidin and derivatives for treatment of retroviral infections Abandoned CA2202467A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO943860A NO943860D0 (no) 1994-10-13 1994-10-13 En kjemisk forbindelse og et preparat til bruk som terapeutikum
NO943860 1994-10-13

Publications (1)

Publication Number Publication Date
CA2202467A1 true CA2202467A1 (en) 1996-04-25

Family

ID=19897498

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2202467 Abandoned CA2202467A1 (en) 1994-10-13 1995-10-10 Use of anthocyanidin and derivatives for treatment of retroviral infections

Country Status (6)

Country Link
EP (1) EP0785790A1 (fi)
AU (1) AU3756995A (fi)
CA (1) CA2202467A1 (fi)
FI (1) FI971459A (fi)
NO (1) NO943860D0 (fi)
WO (1) WO1996011692A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041137A1 (en) * 1996-04-17 1997-11-06 Unifob Use of anthocyanidin and anthocyanidin derivatives
US7737121B2 (en) * 2004-07-29 2010-06-15 Board Of Trustees Of Michigan State University Insulin secretion by anthocyanins and anthocyanidins
EP1882473A1 (en) 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0312222B1 (en) * 1987-10-14 1992-08-05 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of diseases caused by viruses
JPH03209321A (ja) * 1990-01-09 1991-09-12 Toray Ind Inc 抗レトロウイルス薬
JPH03209320A (ja) * 1990-01-09 1991-09-12 Toray Ind Inc 抗レトロウイルス薬

Also Published As

Publication number Publication date
AU3756995A (en) 1996-05-06
WO1996011692A1 (en) 1996-04-25
EP0785790A1 (en) 1997-07-30
FI971459A (fi) 1997-06-05
FI971459A0 (fi) 1997-04-08
NO943860D0 (no) 1994-10-13

Similar Documents

Publication Publication Date Title
Chang et al. Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus
Aquino et al. Plant Metabolites. Structure and in vitro antiviral activity of quinovic acid glycosides from Uncaria tomentosa and Guettarda platyipoda
Van Hoof et al. Plant antiviral agents; VI. 1 3-Methoxyflavones as potent inhibitors of viral-induced block of cell synthesis
Gustafson et al. A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1
JP3571061B2 (ja) B型肝炎ウイルス(hbv)の複製を抑制する薬学的製剤
Hostetler et al. Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3'-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3'-deoxythymidine
JP4397688B2 (ja) 糖尿病またはレトロウイルス関連疾患の予防および治療用医薬の製造におけるスチルベン化合物の使用
Hayashi et al. In vitro and in vivo antiviral activity of scopadulcic acid B from Scoparia dulcis, Scrophulariaceae, against herpes simplex virus type 1
CA1338325C (en) Pharmaceutical composition and method of use
AU8878091A (en) Proanthocyanidin polymers having antiviral activity and methods of obtaining same
EP0256452A2 (en) Antiviral pharmaceutical compositions containing hypericin or pseudohypericin
CA2001898A1 (en) Inhibition of human retroviruses
AU707798B2 (en) Biflavanoids and derivatives thereof as antiviral agents
US5681831A (en) Method of treating viral and retroviral infections including HIV by administration of N6 -(Δ)2 -isopentenyl) adenosine or an analogue thereof
KR960001372B1 (ko) 레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질
Higuchi et al. Antiretroviral activities of anthraquinones and their inhibitory effects on reverse transcriptase
CA2202467A1 (en) Use of anthocyanidin and derivatives for treatment of retroviral infections
WO2023249393A1 (ko) 한약재 추출물을 유효성분으로 포함하는 코로나바이러스 감염증의 예방, 개선 또는 치료용 조성물
WO2023249392A1 (ko) 한약재 추출물을 유효성분으로 포함하는 코로나바이러스 감염증의 예방, 개선 또는 치료용 조성물
EP0297547A2 (en) Use of hydrolyzable tannins for treatement and prophylaxis of AIDS
WO1996011692A9 (en) Use of anthocyanidin and derivatives for treatment of retroviral infections
Borden et al. Effects of amphotericin B and its methyl ester on the antiviral activity of polyinosinic: polycytidylic acid
US5026688A (en) Novel AZT analogs
US5609874A (en) Method of treating viral infections
AU3423989A (en) Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections

Legal Events

Date Code Title Description
FZDE Dead